Devyser has been awarded a funding of EUR 750,000 through the Eurostars-2 program and will join its...
Dr. Dan Hauzenberger, Medical Director, Section of Transplantation Immunology at Sweden’s...
We’re happy to announce that we’ve received certification for the successful completion of a...
Devyser welcomes Fredrik Alpsten as new CEO starting September 1st. Ulf Klangby, the former CEO and...
Swedish genetic test developer Devyser’s product for hereditary breast and ovarian cancer (HBOC) is...
From June 1st to June 7th 2020 is World Haemochromatosis Week.
Stockholm, 26 may 2020
The 8th of May is World Ovarian Cancer Day. Bringing awareness about this illness is especially...
First and foremost, we are ensuring the well-being of our employees and the continuity of our...
Today is World Cancer Day, as advocated by the Union for International Cancer Control. Their global...
Individual and patient privacy concerns have come back into focus with a recent ruling from a US...
Devyser is excited to announce a new partnership with Biotecnomica in Peru! Our products have now...
